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Abstract  
Assessing the severity of the disease at the time of hospitalization can reduce the mortality of patients 
with coronavirus disease 2019 (COVID-19). For this stance, various scoring systems have been 
described to predict mortality rates. Sequential organ failure assessment (SOFA) is one of the scoring 
systems which have been used in this study. In order to calculate the SOFA score, demographic and 
characteristics information, clinical status, and laboratory findings were recorded from 154 patients 
with COVID-19, who have been admitted to the intensive care unit (ICU) for a period of 6 months. SOFA 
score was calculated in three time periods at the time of hospitalization, 72 hours after hospitalization, 
and the last day of hospitalization. Based on the outcome of the disease (death or recovery), patients 
were divided into two groups, and the results were analyzed in both groups. Statistical analysis has 
represented that the SOFA score was significantly higher in patients who died to compare with 
recovered ones in all time periods. Our findings suggest that SOFA scoring system can be used to predict 
mortality rate in ICU admitted COVID-19 patients. 
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1. Introduction  
 In December 2019, several cases of pneumonia 
with unknown etiology were reported in Wuhan City, 
Hubei Province, China. In the early stages of 
pneumonia, symptoms of acute respiratory infection 
occurred, and some patients progressed rapidly to 
acute respiratory failure and other serious 
complications [1]. On February 11, 2020, the World 
Health Organization (WHO) officially named the new 
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coronavirus infection coronavirus disease 2019 
(COVID-19), and the International Committee of the 
Red Cross study group named it as severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) 
[2]. Four months since the advent of COVID-19 in 
China, the disease has spread rapidly to other parts of 
the world and has become an international threat [3]. 
The mortality rate in patients with COVID-19 with 
severe conditions has been reported to be fluctuated 
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between 11% and 61% [1, 4-6]. Various studies have 
shown that COVID-19 affects different organs and its 
complications include pneumonia, liver and kidney 
disorders, heart damage, immunodeficiency, and 
coagulation disorders, which are in the result of cell 
and organotropism [7, 8]. Sepsis is a life-threatening 
complication of infection and occurs in the form of 
physiological, pathological, and biochemical disorders 
[9, 10]. 
One of the key strategies to improve the treatment 
of sepsis is to prioritize patients in terms of the risk of 
adverse outcomes. This can help physicians to 
prioritize initial treatments such as antibiotics and 
fluid therapy [11]. In critically ill patients, early medical 
interventions to reduce mortality depend on effective 
early assessment methods. A scoring system could be 
helpful to determine the prognosis and accelerate 
practical evaluation by physicians to identify these 
patients and could be useful in providing information 
to relatives of patients, treatment decisions, and 
guidance in allocating resources [12]. However, there 
is currently no specific scoring system for evaluating 
patients with COVID-19. The organ failure assessment 
score (SOFA) system can be used to determine 
prognosis and predict mortality. SOFA was first 
described in 1996, and it was used as a tool to evaluate 
organ failure in sepsis and also to evaluate the effects 
of treatments such as mechanical ventilation and 
vasopressor on organ dysfunction [13]. SOFA 
describes dysfunction of various organs through 
several parameters, including oxygenation index (ratio 
of arterial oxygen pressure to the percentage of inhaled 
oxygen), mean arterial pressure, Glasgow Coma Scale, 
creatinine or urine volume, bilirubin, and platelets, 
respectively for the respiratory system, circulation, 
neurology, renal, hepatic and coagulation. Each of 
these parameters is assigned 0 to 4 points, and the sum 
of these points is 0 to 24, which determines the overall 
SOFA score. The higher score indicates the worsening 
of the organ disorder. Numerous studies have shown 
that SOFA can predict morbidity and mortality and 
has been used for evaluation in critically ill patients 
and in the intensive care unit (ICU) [12, 14-16].  
This study has been conducted since there is no 
special scoring system in patients with COVID-19, and 
on the other hand, there is no performed research on 
SOFA score in patients with COVID-19, who have been 
admitted to the ICU in Iran. This present study to 
investigate the clinical characteristics, medical records 
and laboratory results of ICU admitted COVID-19 
patients to further evaluation for the role of SOFA 
score in predicting the complexity of the disease in 
three different time periods and help to identify the 
related factors.  
 
2. Materials and Methods 
2.1 Study design  
This present retrospective analytical cross-
sectional study was performed on patients with 
COVID-19, who have been admitted to the ICU of Razi 
Hospital in Rasht, Iran, after receiving the approval of 
the Vice-Chancellor for Research and the code of 
ethics number IR.GUMS.REC.1399.509.  Inclusion 
criteria included all patients with a definitive diagnosis 
of COVID-19 based on a positive nasopharyngeal PCR 
test, hospitalization in the ICU of Razi Hospital in 
Rasht, Iran, from April 1 to September 22, 2020. 
Exclusion criteria included patients with insufficient 
information about their condition, and also patients 
who had been admitted to the ICU before April 1, 2020 
or were still admitted to the ICU after September 22, 
2020. In this regard, the checklist has been used with 
the following items: age, sex, underlying disease 
history, clinical status, and laboratory results, which 
have been documented in the medical records of ICU, 
admitted COVID-19 patients, to calculate the SOFA 
score. The SOFA score of patients in three time periods 
was calculated at the time of admission to the ICU, 72 
hours after admission, and the last day of 
hospitalization in the ICU. Based on the outcome of 
the disease (death or discharge), patients were divided 
into two groups.  
 
2.2 Data analysis  
 Data analysis was done through SPSS software 
version 22 (SPSS Inc., USA). For variables with 
normal distribution, descriptive analysis was 
performed using mean and standard deviation. 
Number and percentage were used to report 
qualitative variables. Chi-square test, independent t-
test, logistic regression, and Mann Whitney test were 
used to evaluate the study's objectives.  
 
3. Results  
Demographic information, including age, sex, and 
comorbidities in the two groups of discharged and 
deceased patients, is given in Table 1. In general, the 
mean age of the patients was 60.07±15.73 years, with 
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53.2% of males. The Chi-square test has shown no 
statistically significant relationship between gender 
and deceased or recovered patients with COVID-19 
disease (P = 0.54). However, there was a remarkable 
relationship between the two groups in terms of age, 
so that the mean age in the deceased patients was 
higher than the other group (P= 0.002). Also, there 
was a noteworthy relationship between the presence of 
underlying disease in patients admitted to ICU and the 
outcome of treatment, but there was no difference in 
the distribution of underlying disease in hospitalized 
patients (P> 0.05).  
SOFA score analysis with Mann Whitney U test 
has represented a significant difference between SOFA 
score values in the three time periods in the two groups 
(Table 1). Logistic regression on SOFA score at the 
time of admission in the ICU as an intervening variable 
in predicting patient mortality has illustrated that 
increasing each SOFA score at the time of 
hospitalization can increase the probability of 
mortality by 1.27 times (P<0.001). Also, 
logistic regression on SOFA score at 72 hours after 
admission in the ICU as an intervening variable in 
predicting patient mortality has illustrated that 
increasing each SOFA score at 72 hours after 
admission can increase the probability of mortality by 
1.47 times (P<0.001). Logistic regression on SOFA 
score on the last day of hospitalization in the ICU as an 
intervening variable in predicting patient mortality has 
illustrated that increasing each SOFA score on the 
previous day of hospitalization could increase the 
probability of mortality by 1.9 times (P<0.001), Table 
2. Mann Whitney U test has illustrated that there was 
a significant difference between the values of SOFA 
score at the time of admission, 72 hours after 
admission, and the last day of admission according to 
the presence of underlying diseases in the studied 
patients (P = 0.02, P =0.007, P=0.01). Among the 
underlying diseases, there was a significant difference 
between the values of SOFA scores in the studied 
periods only in heart, kidney, and liver diseases. SOFA 
score in heart disease at 72 hours postoperatively, in 
kidney disease in all stages, and in liver disease in the 
first and last day of hospitalization was significantly 
higher than the other group (Table 3).  
 
4. Discussion  
The COVID-19 disease can easily lead to acute 
respiratory distress, multiorgan dysfunction, acute 
heart damage, acute kidney damage, and even death 
in the case of severity [17]. During the corona 
pandemic, the increase in the number of critically ill 
patients and the limited medical resources leads to 
global concern worldwide [18, 19]. Therefore, the 
initial evaluation of patients with severe COVID-19 
disease is crucial for monitoring and early medical 
interventions. Consequently, the important duty of 
physicians is to screen patients with a high mortality 
rate among very critically ill patients [20]. A scoring 
system can help physicians to be quick and accurate 
diagnosis to make treatment decisions. However, a 
simple and effective way to assess the severity and 
outcome of patients with COVID-19 is challenging for 
physicians [17]. The SOFA score is one of the scoring 
systems that is used to assess organ failure and can 
predict the severity and outcome of the disease. For 
this purpose, the SOFA scale is used in the health care 
system, which has high accuracy, but on the other 
hand, it’s complicated and time-consuming because it 
requires the evaluation of several parameters [17, 21]. 
A study has reported that modified sequential organ 
failure assessment (MSOFA) score also can be useful 
as well as the SOFA and it’s easier to implement in 
resource-constrained settings [22]. Organ dysfunction 
is associated with a high mortality rate and a large 
percentage of the budget in the ICU. The SOFA score 
can be used to assess organ dysfunction or failure and 
morbidity. However, this system was first developed to 
describe organ function rather than predict patient 
outcomes. Studies have shown a remarkable 
association between organ function discrepancy and 
mortality [23].  
Since there is no special scoring system for risk 
assessment in patients with COVID-19, we conducted 
this study to evaluate the effectiveness of the SOFA 
score in critically ill patients to identify an effective risk 
scoring system in COVID-19 patients. This present 
study has represented that the SOFA score was higher 
in patients who died to compare with recovered ones 
in all time periods. Also, based on logistic regression, 
the SOFA score was identified as a predictor of 
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A study by Liu et al. [24] has evaluated the efficacy 
of SOFA compared to quick SOFA (qSOFA) Score, 
which identifies patients outside the ICU with 
suspected infection that are at a high risk for in-
hospital mortality and is composed of 3 variables 
(respiratory rate, systolic blood pressure, and altered 
mental status), in predicting the outcome of patients 
with COVID-19, SOFA≥3, and qSOFA≥1 are related to 
mortality in severe COVID-19 disease. In addition, 
SOFA is a very sensitive marker in diagnosing in-
hospital mortality and is preferred to qSOFA for 
predicting outcomes [21]. Another study by Raith et 
al., which has been conducted to evaluate the power of 
SOFA, qSOFA, and Systemic Inflammatory Response 
Syndrome (SIRS) criteria, which assessment includes 
4 clinical variables (temperature, heart rate, 
respiratory rate, and white blood cell count), in 
predicting the outcome of patients suspected of 
infection admitted to the ICU, has reported that 
increasing SOFA score is more than twice as strong 
predictor for mortality in comparison to qSOFA and 
SIRS criteria [10]. Yang et al. by considering 60-day 
mortality, have reported the patients with a higher 
SOFA score (5≤) had a higher risk of mortality than 
patients with a lower SOFA score (5≥), which is similar 
to our study [17]. Also, in the study of Chen et al., SOFA 
score, along with old age and high underlying disease, 
were identified as two independent risk factors for 
death in patients with COVID-19 [12].  However, a 
study by Raschke et al., which examined the accuracy 
of the SOFA score to determine the possible mortality 
of patients with COVID-19 pneumonia requiring 
mechanical ventilation, showed that the power of 
SOFA to predict mortality in patients with COVID-19 
pneumonia was weak and significantly less valuable 
than the age factor [25]; they justified the results by 
referring to the previous studies, which stated SOFA 
score in 3 subgroups (pulmonary,  hepatic and renal 
disease) and the relation with mortality in COVID-19 
patients [25, 26]. Our study showed that there was a 
statistically significant relationship between SOFA 
score and underlying disease at baseline, 72 hours 
after hospitalization, and the last day of 
hospitalization.  
Table 1. Demographic, clinical findings and SOFA values of hospitalized patients by treatment outcome 
 
Variables Death Recovery P value 
Gender 
Male 45 (54.9) 37 (45.1) 
0.54 
Female 43 (59.7) 29 (40.3) 
Age (Mean ± SD) 63.45 ± 14.78 55.57 ± 15.94 0.002 
Underlying disease 
Yes 73 (62.4) 44 (37.6) 
0.019 
No 15 (40.5) 22 (59.5) 
Underlying disease 
Diabetes 24 (47.1) 27 (52.9) 0.49 
High blood pressure 22 (34.4) 42 (65.6) 0.07 
Heart disease 16 (36.4) 28 (63.6) 0.30 
Respiratory disease 8 (36.4) 14 (63.6) 0.50 
Kidney disease 5 (33.3) 10 (67.7) 0.43 
Liver disease - 3 (100) 0.26 
Neurological disease 4 (36.4) 7 (63.6) 0.65 
Malignancy 6 (42.9) 8 (57.1) 1.00 
Rheumatic disease 3 (60) 2 (40) 0.65 
SOFA score 
At the time of admission 8.76 ± 3.69 6.12 ± 2.87 0.0001 
72 hours after admission 9.92 ± 3.9 5.6 ± 2.76 0.0001 
Last day of admission 11.07 ± 3.92 4.65 ± 2.09 0.0001 
 
Table 2. Comparison of SOFA Score predictive power by measurement times 
 
Variables Time of admission Incidence rate (OR) Confidence interval (CI) P value 
SOFA score 
At the time of admission 1.27 1.13-1.42 <0.001 
72 hours after admission 1.47 1.27-1.70 <0.001 
Last day of admission 1.90 1.55-2.34 <0.001 
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SOFA levels in patients with underlying disease 
were higher in all stages than in patients without 
underlying disease. Studies have shown that patients 
with a history of previous underlying disease are at 
Table 3. Comparison of SOFA Score scores in the studied time periods according to the 
presence or absence of underlying disease in hospitalized patients 
 
Variables SOFA Score Underlying disease Mean ± SD P value 
Underlying disease 
At the time of admission 
Yes 7.95 ± 3.58 
0.02 
No 6.59 ± 3.53 
72 hours after admission 
Yes 8.33 ± 4.05 
0.007 
No 6.5 ± 3.67 
Last day of admission 
Yes 8.74 ± 4.45 
0.01 
No 7.0 ± 4.7 
High blood pressure 
At the time of admission 
Yes 8.04 ± 3.77 
0.26 
No 7.33 ± 3.47 
72 hours after admission 
Yes 8.73 ± 3.81 
0.10 
No 7.48 ± 4.14 
Last day of admission 
Yes 8.9 ± 4.27 
0.09 
No 7.91 ± 4.73 
Diabetes 
At the time of admission 
Yes 7.8 ± 3.42 
0.54 
No 7.54 ± 3.7 
72 hours after admission 
Yes 7.89 ± 3.63 
0.52 
No 7.8 ± 4.2 
Last day of admission 
Yes 8.29 ± 3.8 
0.49 
No 8.33 ± 4.91 
Heart disease 
At the time of admission 
Yes 8.02 ± 3.48 
0.27 
No 7.47 ± 3.65 
72 hours after admission 
Yes 9.12± 4.12 
0.01 
No 7.36 ± 3.9 
Last day of admission 
Yes 9.45 ± 4.81 
0.05 
No 7.87 ± 4.39 
Respiratory 
At the time of admission 
Yes 7.36 ± 4.06 
0.49 
No 7.67 ± 3.53 
72 hours after admission 
Yes 8.05 ± 5.18 
0.83 
No 7.79 ± 3.83 
Last day of admission 
Yes 8.0 ± 4.54 
0.68 
No 8.37 ± 4.57 
Kidney disease 
At the time of admission 
Yes 11.0 ± 3.96 
0.001 
No 7.26 ± 3.38 
72 hours after admission 
Yes 10.84 ± 4.01 
0.005 
No 7.47 ± 3.89 
Last day of admission 
Yes 3.4± 13.11 
0.01 
No 8.02 ± 4.49 
Liver disease 
At the time of admission 
Yes 14.00 ± 1.73 
0.01 
No 7.50 ± 3.52 
72 hours after admission 
Yes 14.00 ± 7.07 
0.10 
No 7.72 ± 3.92 
Last day of admission 
Yes 17.66 ± 1.15 
0.004 
No 8.13 ± 4.4 
Neurologic disease 
At the time of admission 
Yes 7.81 ± 2.89 
0.61 
No 7.61 ± 3.66 
72 hours after admission 
Yes 6.8 ± 4.26 
0.37 
No 7.92 ± 4.01 
Last day of admission 
Yes 7.54 ± 4.82 
0.65 
No 8.38 ± 4.55 
Malignancy 
At the time of admission 
Yes 8.0 ± 3.78 
0.62 
No 7.59 ± 3.6 
72 hours after admission 
Yes 8.66 ± 4.79 
0.45 
No 7.74 ± 3.94 
Last day of admission 
Yes 9.35 ± 5.25 
0.37 
No 8.22 ± 4.49 
Rheumatic disease 
At the time of admission 
Yes 6.4 ± 2.5 
0.55 
No 7.67 ± 3.63 
72 hours after admission 
Yes 5.66 ± 1.15 
0.41 
No 7.88 ± 4.05 
Last day of admission 
Yes 5.2 ± 3.76 
0.07 
No 8.42 ± 4.55 
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higher risk of death [27]. Among the underlying 
diseases, liver disease was one of the cases that showed 
a significant relationship with SOFA levels at the 
beginning of hospitalization and also on the last day of 
hospitalization. Patients with COVID-19 who had a 
history of liver disease had a higher SOFA score than 
patients without liver disease at the time of admission. 
Patients with liver disease, especially uncompensated 
cirrhosis due to immune dysfunction, may be more 
susceptible to infection with SARS-COV-2 [28]. 
However, due to primary reports, 2-11% of COVID-19 
patients had a history of liver disease, but the true 
prevalence of COVID-19 among liver disease remains 
unknown [28, 29]. These patients show poor 
prognosis when admitted to the ICU, especially in the 
case of dysfunction or multiple organ failure [30]. 
Among the underlying diseases, kidney disease was 
one of the cases that had a significant relationship with 
SOFA levels at the beginning of hospitalization, 72 
hours after hospitalization, and the last day of 
hospitalization in our survey. Patients with COVID-19 
with a history of chronic kidney disease had higher 
SOFA scores than patients without kidney disease at 
all stages of the measurement. Having chronic 
underlying kidney disease is associated with a higher 
rate of in-hospital mortality. Also, patients with 
dialysis-dependent renal failure have the highest risk 
of in-hospital death compared to patients who do not 
undergo dialysis [31]. A study by Goswami et al. was 
conducted to evaluate the effectiveness of SOFA and 
other scoring systems on the outcome of patients with 
chronic kidney disease admitted to the ICU, which has 
represented that each SOFA score increase mortality 
significantly in 30-day period. Also, the sensitivity and 
specificity of SOFA ≥10.5 in predicting 30-day 
mortality are 85% and 100%, respectively [32]. Heart 
disease was another underlying disease in patients 
with COVID-19 that had a statistically significant 
relationship with SOFA levels in 72 hours after 
hospitalization and the last day of hospitalization. 
According to new studies, the SOFA score is a strong 
predictor in the cardiac intensive care unit [33]. 
Studies have shown that the clinical outcome is severe 
in patients with COVID-19 with a history of 
cardiovascular disease. A history of cardiovascular 
disease and the presence of cardiovascular risk factors 
make patients with COVID-19 vulnerable. In addition, 
COVID-19 can exacerbate underlying cardiovascular 
disease and even predispose these patients to new 
cardiac complications [34, 35]. Although several 
studies have been performed to evaluate the efficacy of 
the SOFA scoring system in patients with COVID-19 
disease, few studies have systematically evaluated the 
accuracy of SOFA in diagnosing the severity of 
COVID-19 disease and its predictive value. Also, 
according to our investigation, this is the first study 
that evaluated the sofa score in 3 time periods in 
critically ill patients with COVID-19, which is the 
strength of our study. However, this study had some 
limitations; one of these limitations was the study's 
sample size. Certainly, studies with a large number of 
critically ill patients with COVID-19 can more 
accurately assess the efficiency of the SOFA scoring 
system. This study was a single-center study. Due to 
limited treatment resources and the impossibility of 
providing an intensive care bed for all critically ill 
patients, many of these patients were not admitted to 
the ICU. Extra multicenter studies should be done in 
longer time periods to enhance the SOFA Score's 
efficiency. Also, other scoring systems are widely used 
in the ICU. It is recommended that the effectiveness of 
these scoring systems in patients with COVID-19 be 
evaluated in future studies.   
In summary, the SOFA scoring system at the 
beginning of hospitalization and 72 hours after 
hospitalization can be used to predict mortality in 
critically ill patients with COVID-19 who have been 
admitted to the ICU. 
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